№ files_lp_4_process_3_136738
File format: docx
Character count: 47539
File size: 55 KB
A scholarly review article summarising clinical evidence, underlying mechanisms, and practical considerations for exclusive enteral nutrition in children with Crohn’s disease, including its impact on inflammation, immune response, microbiota, and growth outcomes.
Year:
2017
Region:
International (studies from Europe, Australasia, North America)
Topic:
Paediatric Crohn’s disease, nutrition therapy
Document type:
Review article
Institution:
Southampton Children’s Hospital, University of Southampton
Authors:
James J Ashton, Joan Gavin, R Mark Beattie
Keywords:
Crohn’s disease, nutrition, paediatric, exclusive enteral nutrition
Population:
Children and selected adult patients with Crohn’s disease
Study period:
1980–2017
Evidence sources:
Randomised controlled trials, observational studies, retrospective studies, meta-analyses, review articles, editorials, conference abstracts, case reports
Main focus:
Induction of remission, immune modulation, microbiome changes, growth and nutritional outcomes
Guideline references:
ECCO, ESPGHAN, NASPGHAN, ESPEN
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
Australia
Subject:
Health care, Enteral feeding
Document type:
Health care procedure
Organization / institution:
Aruma
Author:
Aruma staff
Target audience:
Aruma staff, health professionals, caregivers
Period of validity:
Ongoing
Approval date:
Not specified
Amendment date:
Not specified
Year:
2023
Region / City:
Plano, Texas
Topic:
Medical Guidelines for Enteral Feeding
Document Type:
Administrative Guideline
Organization:
Plano Independent School District
Author:
Plano ISD Medical Officer
Target Audience:
School Nurses, Medical Staff, Caregivers
Effective Period:
Annual (with yearly updates)
Approval Date:
N/A
Amendment Date:
N/A
Year:
2023
Region / City:
Global
Topic:
Pediatric IBD, Enteral Nutrition
Document Type:
Questionnaire
Institution:
ESPGHAN, Canadian Pediatric IBD Network
Author:
Eytan
Target Audience:
Pediatric gastroenterologists, pediatric gastroenterology nurses, pediatric gastroenterology dietitians
Period of Validity:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Context:
International survey aimed at improving enteral nutrition care practices for children with IBD by collecting data from global healthcare professionals on treatment protocols and challenges.
Year:
2026
Department / Organization:
Pharmacy Department
Document Type:
Information leaflet
Target Audience:
Parents and carers of children with enteral feeding tubes
Content Focus:
Medication administration guidelines, tube types, liquid and solid drug preparations
Applicable Age Group:
Pediatric patients
Instructions Validity:
Immediate use following preparation
Safety Considerations:
Tube blockage prevention, proper drug handling, formulation-specific advice
Contact Information:
Doctor, nurse, pharmacist
Year:
Not specified
Region / City:
Not specified
Topic:
Infliximab dose escalation in Crohn’s disease treatment
Document type:
Medical request letter
Institution / Organization:
Not specified
Author:
Not specified
Target audience:
Insurance company
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
Year:
[Insert Year]
Region / City:
[Insert City, State ZIP]
Topic:
Medical treatment authorization
Document type:
Request letter
Organization / Institution:
[Insert Organization Name]
Target audience:
Medical Director, Payer (Insurance Company)
Period of validity:
[Insert Start Date] - [Insert End Date]
Approval date:
[Insert Date of Approval]
Amendment date:
[Insert Date of Changes if any]
Year:
2026
Region / city:
Multiple centers
Topic:
Medical research, Crohn’s disease
Document type:
Research study
Organization / institution:
Various medical institutions
Author:
Not specified
Target audience:
Medical professionals, researchers
Period of validity:
N/A
Approval date:
N/A
Modification date:
N/A
Year:
2024
Region / city:
Tangier, Morocco
Topic:
Inflammatory Bowel Disease, Crohn’s Disease
Document Type:
Research Study
Organization / Institution:
Mohamed VI University Hospital, Hepato-Gastroenterology Department
Authors:
K. Attaqi, F.Z. Bouamama, S. Temsamani, A. Akjay, H. Ouaya, H. Meyiz, I. Mellouki
Target Audience:
Medical professionals, gastroenterologists
Period of Action:
2020-2024
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / City:
Not specified
Document type:
Medical Case Report
Organization / Institution:
Not specified
Author:
Nicole Wiebe, Liena Zhao, Jessica P. Woolfson
Target audience:
Healthcare professionals, pediatric gastroenterologists
Period of action:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2022
Country:
United States
Study name:
Study of a Prospective Adult Research Cohort with IBD (SPARC IBD)
Affiliated organization:
Crohn’s & Colitis Foundation
Study type:
Prospective cohort study
Number of centers:
17
Population:
Adult patients with Crohn’s disease initiating vedolizumab or ustekinumab after anti-TNF therapy
Exposures:
Ustekinumab, Vedolizumab, Anti-TNF inhibitors
Outcomes:
Treatment discontinuation, Crohn’s disease–related surgery, malignancy, cardiac events, thromboembolic events
Data sources:
Commercial claims data, SPARC IBD cohort data
Coding systems:
ICD-10-CM, ICD-10-PCS, HCPCS Level I and II, CPT-4, NDC
Sample size (SPARC IBD subset):
Vedolizumab n=77; Ustekinumab n=227
Primary measures:
Incidence rates per 1000 person-years, hazard ratios with 95% confidence intervals
Citation:
Raffals LE, Saha S, Bewtra M, et al. Inflamm Bowel Dis 2022;28:192–199
Year:
2026
Study Type:
Clinical trial
Phase:
Phase 2
Intervention:
Tesnatilimab, Ustekinumab, Placebo
Primary Endpoint:
Change from baseline in CDAI score at Weeks 8 and 12
Secondary Endpoints:
Clinical remission, clinical response, PRO-2 score, SES-CD, GHAS
Analysis Methods:
ANCOVA, MMRM, Cochran-Mantel-Haenszel chi-square test, Multiple Comparison Procedures
Sample Size:
60 patients per arm (Week 8), 50 patients per arm (Week 12)
Power:
84% (Week 8), 85% (Week 12)
Error Rate:
0.05 (two-sided)
Covariates:
Baseline CDAI score, SNP-positive status, Bio-IR status, study visit, visit-by-treatment interaction
Year:
2015
Region / City:
Chicago
Theme:
Health insurance, public sector
Document type:
Request for Proposal (RFP)
Organ / Institution:
City of Chicago, Chicago Park District, Chicago Public Schools
Author:
City of Chicago Department of Finance
Target audience:
Organizations with experience in HMO and/or Prescription Drug solutions
Period of validity:
January 1, 2016 - (contract term)
Approval date:
Not specified
Amendment date:
Not specified
Year:
2016
Region / City:
Wellington, New Zealand
Theme:
Environmental regulation, Space industry
Document type:
Discussion document
Organization:
Ministry for the Environment
Author:
Ministry for the Environment
Target audience:
General public, stakeholders in space industry, environmental regulators
Period of validity:
Not specified
Date of approval:
Not specified
Date of amendments:
Not specified
Year:
2021
Region / City:
Bedfordshire & Luton
Topic:
Eating Disorders Awareness
Document Type:
Interview
Author:
Sarah Fuller
Target Audience:
General public, healthcare professionals, individuals affected by eating disorders
Period of Action:
2021
Approval Date:
4 December 2021
Date of Changes:
N/A
Date:
03-04 May 2024
Time:
08:45 am - 05:00 pm
Venue:
Bangladesh-Japan Training Institute, Room # 7, 7th Floor, Eastern Plaza, Sonargaon Road, Dhaka
Registration Deadline:
02 May 2024
Year:
2024
Region / City:
Dhaka
Topic:
L/C Management, Export-Import Business
Document Type:
Training Program
Organization:
Bangladesh-Japan Training Institute
Author:
Mr. Md. Arif Khan, Chief Consultant & Training Specialist
Target Audience:
Business owners, individuals interested in export-import business, business graduates
Period of Validity:
May 2024
Approval Date:
03-04 May 2024
Amendment Date:
N/A
Author:
Jeremiah John Ackah
Position:
Health Promotion Officer
Thematic focus:
Child health promotion, vaccination, exclusive breastfeeding, safe motherhood
Type of document:
Analytical article
Key concepts:
Vaccination, Exclusive Breastfeeding, Safe Motherhood, Diffusion of Innovation Theory
Programs mentioned:
Expanded Program on Immunization (EPI), Safe Motherhood Programs
International organizations referenced:
World Health Organization, Centers for Disease Control and Prevention, United Nations
Commemorative date mentioned:
World Child Health Promotion Day (April 7)
Diseases referenced:
Measles, Polio, Whooping cough (Pertussis), Diphtheria, Tetanus, Hepatitis B, Haemophilus influenzae type b (Hib), Pneumococcal disease, Rotavirus, Meningitis
Sources cited:
World Health Organization (2020); Centers for Disease Control and Prevention (2020); Rogers, E. M. (2003); United Nations (2020)
Year:
1997
Date of Publication:
October 30, 1997
Place of Interview:
Anlong Veng, Dangrek Mountains, Cambodia
Publication:
Far Eastern Economic Review
Journalist:
Nate Thayer
Type of Document:
Magazine cover story interview
Primary Subject:
Pol Pot
Related Figures:
Ta Mok; Son Sen; Hun Sen; Le Duan; Le Duc Tho
Historical Period Discussed:
Khmer Rouge rule, 1975–1978
Political Movement:
Khmer Rouge (Democratic Kampuchea)
Themes:
Responsibility for mass deaths; internal party conflict; relations with Vietnam; ideological justification; personal testimony
Length:
Two-hour interview
Year:
2022
Region / City:
Fort Lauderdale, FL
Industry:
Automotive Sales
Document Type:
Press Release
Organization:
Haig Partners LLC
Author:
John Davis, Aimee Allen
Target Audience:
Automotive industry professionals, potential buyers, investors
Effective Period:
September 15, 2022
Approval Date:
September 15, 2022
Modification Date:
Not specified
Year:
2020
Region / City:
Not specified
Theme:
Educational intervention, cognitive development, behavioral change
Document type:
Research article
Author:
Dr. Shruti Marwaha, Vijay Singh, Mukesh Boobalan, Sandip Sampatrao Bobade
Target audience:
Educators, researchers, parents
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Keywords:
Confidence, creative quotient, decision making ability, focus factor, intelligence quotient